Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhild Wildner

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Progress in Retinal and Eye Research|November 29, 2011
Interplay between innate and adaptive immunity in the development of non-infectious uveitisFrançois Willermain, James T Rosenbaum, Bahram Bodaghi, et al.
Cancer Research|May 31, 2002
Recessive transmission of a multiple endocrine neoplasia syndrome in the ratAndreas Fritz, Axel Walch, Kamilla Piotrowska, et al.
Clinical & Developmental Immunology|March 5, 2008
CRALBP is a highly prevalent autoantigen for human autoimmune uveitisCornelia A Deeg, Albert J Raith, Barbara Amann, et al.
Frontiers in Immunology|June 26, 2023
Increased plasma level of terminal complement complex in AMD patients: potential functional consequences for RPE cellsCatharina Busch, Saskia Rau, Andjela Sekulic, et al.
Frontiers in Medicine|November 3, 2022
A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis - A phase I clinical trialStephan Thurau, Christoph M E Deuter, Arnd Heiligenhaus, et al.
Cytokine|December 25, 2016
Glycosaminoglycans are important mediators of neutrophilic inflammation in vivoMartha Gschwandtner, Elisabeth Strutzmann, Mauro M Teixeira, et al.
Autoimmunity Reviews|February 1, 2017
Inflammatory eye disease: Pre-treatment assessment of patients prior to commencing immunosuppressive and biologic therapy: Recommendations from an expert committeeDenis Wakefield, Peter McCluskey, Gerhild Wildner, et al.
Molecular Therapy. Methods & Clinical Development|February 26, 2025
A novel platform for engineered AAV-based vaccinesSabrina Babutzka, Miranda Gehrke, Anastasia Papadopoulou, et al.
Frontiers in Immunology|July 1, 2017
Anaphylatoxins Activate Ca<sup>2+</sup>, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment EpitheliumCatharina Busch, Balasubramaniam Annamalai, Khava Abdusalamova, et al.
Journal of Neuroinflammation|October 23, 2022
FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degenerationAhmad Samir Alfaar, Lucas Stürzbecher, Maria Diedrichs-Möhring, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Progress in Retinal and Eye Research|November 29, 2011
Interplay between innate and adaptive immunity in the development of non-infectious uveitisFrançois Willermain, James T Rosenbaum, Bahram Bodaghi, et al.
Cancer Research|May 31, 2002
Recessive transmission of a multiple endocrine neoplasia syndrome in the ratAndreas Fritz, Axel Walch, Kamilla Piotrowska, et al.
Clinical & Developmental Immunology|March 5, 2008
CRALBP is a highly prevalent autoantigen for human autoimmune uveitisCornelia A Deeg, Albert J Raith, Barbara Amann, et al.
Frontiers in Immunology|June 26, 2023
Increased plasma level of terminal complement complex in AMD patients: potential functional consequences for RPE cellsCatharina Busch, Saskia Rau, Andjela Sekulic, et al.
Frontiers in Medicine|November 3, 2022
A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis - A phase I clinical trialStephan Thurau, Christoph M E Deuter, Arnd Heiligenhaus, et al.
Cytokine|December 25, 2016
Glycosaminoglycans are important mediators of neutrophilic inflammation in vivoMartha Gschwandtner, Elisabeth Strutzmann, Mauro M Teixeira, et al.
Autoimmunity Reviews|February 1, 2017
Inflammatory eye disease: Pre-treatment assessment of patients prior to commencing immunosuppressive and biologic therapy: Recommendations from an expert committeeDenis Wakefield, Peter McCluskey, Gerhild Wildner, et al.
Molecular Therapy. Methods & Clinical Development|February 26, 2025
A novel platform for engineered AAV-based vaccinesSabrina Babutzka, Miranda Gehrke, Anastasia Papadopoulou, et al.
Frontiers in Immunology|July 1, 2017
Anaphylatoxins Activate Ca<sup>2+</sup>, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment EpitheliumCatharina Busch, Balasubramaniam Annamalai, Khava Abdusalamova, et al.
Journal of Neuroinflammation|October 23, 2022
FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degenerationAhmad Samir Alfaar, Lucas Stürzbecher, Maria Diedrichs-Möhring, et al.
Pageof 7